RavenQuest BioMed Inc.
RVVQF · OTC
10/31/2018 | 10/31/2017 | 10/31/2016 | 10/31/2015 | |
|---|---|---|---|---|
| Market Cap | $62,302 | $43,110 | $40,048 | $39,045 |
| - Cash | $363 | $3,380 | $1 | $2 |
| + Debt | $13,259 | $233 | $84 | $52 |
| Enterprise Value | $75,198 | $39,964 | $40,131 | $39,095 |
| Revenue | $1,257 | $112 | $0 | $0 |
| % Growth | 1,018.8% | – | – | – |
| Gross Profit | $801 | $15 | $0 | $0 |
| % Margin | 63.7% | 13% | – | – |
| EBITDA | -$27,261 | -$3,154 | -$81 | -$76 |
| % Margin | -2,168.7% | -2,807.3% | – | – |
| Net Income | -$30,468 | -$3,301 | -$81 | -$76 |
| % Margin | -2,423.9% | -2,938.1% | – | – |
| EPS Diluted | -0.33 | -0.1 | -0.003 | -0.003 |
| % Growth | -230% | -3,471.4% | -7.7% | – |
| Operating Cash Flow | -$11,102 | -$2,510 | -$32 | -$20 |
| Capital Expenditures | -$12,260 | -$1 | $0 | $0 |
| Free Cash Flow | -$23,362 | -$2,511 | -$32 | -$20 |